<?xml version="1.0" ?>
<DOC>
   <DOCID>LA012594-0117</DOCID>
   <HEADLINE> BRIEFCASE : HEALTH_CARE ; ONCOTECH JOINS UCI TO WORK_ON OVARIAN CANCER VACCINE</HEADLINE>
   <TEXT> Though it has yet to sell any drugs on the market , Oncotech Inc. is nonetheless expanding its product_line . The 8-year-old , privately held biotechnology firm in Irvine just signed a deal with UC Irvine and its Orange-based medical_center to develop a vaccine for deadly ovarian cancer . The company , which earns income by providing lab work_on biopsies for local cancer centers , is working to develop two cancer-fighting drugs -- one with Cornell University , Chief_Executive Frank Kiesner said . Kiesner said that the newest development deal is based on research by Morrie Granger , professor of molecular_biology and biochemistry at UCI . The company will provide funding as well as laboratory help in developing the drug .</TEXT>
</DOC>
